Allogenic Blood Transfusion Following Total Hip Arthroplasty: Results from the Nationwide Inpatient

Sample, 2000 to 2009

by Anas Saleh, Travis Small, Aiswarya Lekshmi Pillai Chandran Pillai, Nicholas K. Schiltz, Alison K. Klika, and Wael K. Barsoum

J Bone Joint Surg AmVolume 96(18):e155September 17, 2014

©2014 by The Journal of Bone and Joint Surgery, Inc.

Diagram showing the number of excluded, transfused, and non-transfused cases from the total hip arthroplasty cohort (U.S., 2000 to 2009).

Anas Saleh et al. J Bone Joint Surg Am 2014;96:e155

©2014 by The Journal of Bone and Joint Surgery, Inc.

Graph showing the adjusted rates of allogenic, autologous, and overall blood transfusion among total hip arthroplasty patients in the U.S.

Anas Saleh et al. J Bone Joint Surg Am 2014;96:e155

©2014 by The Journal of Bone and Joint Surgery, Inc.

Graph showing the prevalence of comorbidities in patients receiving and not receiving a blood transfusion following total hip arthroplasty.

Anas Saleh et al. J Bone Joint Surg Am 2014;96:e155

©2014 by The Journal of Bone and Joint Surgery, Inc.

Graph showing the adjusted effect of allogenic blood transfusion on the outcomes after total hip arthroplasty.

Anas Saleh et al. J Bone Joint Surg Am 2014;96:e155

©2014 by The Journal of Bone and Joint Surgery, Inc.